Biomarkers in Patients Hospitalized With Suspected Acute Myocardial Infarction
Completed
- Conditions
- Myocardial Infarction, Acute
- Registration Number
- NCT04167904
- Lead Sponsor
- St. Olavs Hospital
- Brief Summary
The concentration of troponins in plasma is used for diagnosing acute myocardial infarction. Different types of heart-specific troponins can be measured and with different analytical methods. The primary aim of this study is to evaluate the diagnostic characteristics of a new analytical method for measuring troponin I in diagnosing acute myocardial infarction.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 4446
Inclusion Criteria
- hospitalized at St. Olavs hospital
- blood sampled for troponin analysis due to suspicion of acute myocardial infarction without ST-elevations on ECG less than 4 hours after admitted to the hospital
Exclusion Criteria
- residency outside Norway
- does not understand Norwegian
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Acute myocardial infarction according to the 4th universal definition of myocardial infarction Before discharge from hospital, a median of 2 days Metric: Yes/No
- Secondary Outcome Measures
Name Time Method Days between hospital discharge and acute myocardial infarction according to the 4th universal definition of myocardial infarction Within 30 days after hospital discharge Metric: Days.
Days between hospital discharge and death Within 30 days after hospital discharge Metric: Days. The secondary outcome measures will be combined into a composite endpoint reflecting the time between hospital admission and the first secondary outcome measure
Days between hospital discharge and coronary revascularization Within 30 days after hospital discharge Metric: Days
Trial Locations
- Locations (1)
St Olavs hospital
🇳🇴Trondheim, Norway